Serum MFAP4, a novel potential biomarker for liver cirrhosis screening, correlates with transient elastography in NAFLD patients

Abstract Background and Aim Non‐alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in different countries. Liver fibrosis is considered as the most appropriate predictor of NAFLD‐associated outcome. Microfibrillar‐associated protein 4 (MFAP4) is a glycoprotein locate...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Reine Kanaan, Cesar Yaghi, Carole Saade Riachy, Anders Schlosser, Aline Hamade, Uffe Holmskov, Myrna Medlej‐Hashim, Grith Lykke Sørensen, Rania Jounblat
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Wiley 2023-03-01
Ráidu:	JGH Open
Fáttát:	cirrhosis MFAP4 non‐alcoholic fatty liver disease serum biomarker transient elastography
Liŋkkat:	https://doi.org/10.1002/jgh3.12873
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!